Literature DB >> 23542128

The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.

Nurit Keinan1, Hadas Pahima, Danya Ben-Hail, Varda Shoshan-Barmatz.   

Abstract

The voltage-dependent anion channel (VDAC), located at the outer mitochondria membrane (OMM), mediates interactions between mitochondria and other parts of the cell by transporting anions, cations, ATP, Ca(2+), and metabolites. Substantial evidence points to VDAC1 as being a key player in apoptosis, regulating the release of apoptogenic proteins from mitochondria, such as cytochrome c, and interacting with anti-apoptotic proteins. Recently, we demonstrated that VDAC1 oligomerization is a general mechanism common to numerous apoptogens acting via different initiating cascades and proposed that a protein-conducting channel formed within a VDAC1 homo/hetero oligomer mediates cytochrome c release. However, the molecular mechanism responsible for VDAC1 oligomerization remains unclear. Several studies have shown that mitochondrial Ca(2+) is involved in apoptosis induction and that VDAC1 possesses Ca(2+)-binding sites and mediates Ca(2+) transport across the OMM. Here, the relationship between the cellular Ca(2+) level, [Ca(2+)]i, VDAC1 oligomerization and apoptosis was studied. Decreasing [Ca(2+)]i using the cell-permeable Ca(2+) chelating reagent BAPTA-AM was found to inhibit VDAC1 oligomerization and apoptosis, while increasing [Ca(2+)]i using Ca(2+) ionophore resulted in VDAC1 oligomerization and apoptosis induction in the absence of apoptotic stimuli. Moreover, induction of apoptosis elevated [Ca(2+)]i, concomitantly with VDAC1 oligomerization. AzRu-mediated inhibition of mitochondrial Ca(2+) transport decreased VDAC1 oligomerization, suggesting that mitochondrial Ca(2+) is required for VDAC1 oligomerization. In addition, increased [Ca(2+)]i levels up-regulate VDAC1 expression. These results suggest that Ca(2+) promotes VDAC1 oligomerization via activation of a yet unknown signaling pathway or by increasing VDAC1 expression, leading to apoptosis. This article is part of a Special Issue entitled: 12th European Symposium on Calcium.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542128     DOI: 10.1016/j.bbamcr.2013.03.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  36 in total

1.  Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.

Authors:  Danya Ben-Hail; Racheli Begas-Shvartz; Moran Shalev; Anna Shteinfer-Kuzmine; Arie Gruzman; Simona Reina; Vito De Pinto; Varda Shoshan-Barmatz
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

2.  Picroside II Exerts a Neuroprotective Effect by Inhibiting mPTP Permeability and EndoG Release after Cerebral Ischemia/Reperfusion Injury in Rats.

Authors:  Shan Li; Tingting Wang; Li Zhai; Keli Ge; Jun Zhao; Weihong Cong; Yunliang Guo
Journal:  J Mol Neurosci       Date:  2017-12-18       Impact factor: 3.444

3.  Crystal structural characterization reveals novel oligomeric interactions of human voltage-dependent anion channel 1.

Authors:  Toshiaki Hosaka; Masateru Okazaki; Tomomi Kimura-Someya; Yoshiko Ishizuka-Katsura; Kaori Ito; Shigeyuki Yokoyama; Kosuke Dodo; Mikiko Sodeoka; Mikako Shirouzu
Journal:  Protein Sci       Date:  2017-06-21       Impact factor: 6.725

4.  Lack of PGC-1α exacerbates high glucose-induced apoptosis in human umbilical vein endothelial cells through activation of VADC1.

Authors:  Hui Peng; Wenyu Zhong; Hong Zhao; Li Chen; Xiao Zhou; Feng Li; Weiwei Zhu; Guimei Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 5.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 6.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

7.  Mitochondrial Ca(2+) influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction.

Authors:  M-S Hwang; C T Schwall; E Pazarentzos; C Datler; N N Alder; S Grimm
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

8.  Striated muscle-specific serine/threonine-protein kinase beta segregates with high versus low responsiveness to endurance exercise training.

Authors:  Denis Kusić; Joanne Connolly; Heikki Kainulainen; Ekaterina A Semenova; Oleg V Borisov; Andrey K Larin; Daniil V Popov; Edward V Generozov; Ildus I Ahmetov; Steven L Britton; Lauren G Koch; Jatin G Burniston
Journal:  Physiol Genomics       Date:  2019-12-02       Impact factor: 3.107

Review 9.  Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease.

Authors:  M Rodríguez-Arribas; S M S Yakhine-Diop; J M Bravo-San Pedro; P Gómez-Suaga; R Gómez-Sánchez; G Martínez-Chacón; J M Fuentes; R A González-Polo; M Niso-Santano
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

10.  Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels.

Authors:  Yansheng Feng; Ngonidzashe B Madungwe; Abdulhafiz D Imam Aliagan; Nathalie Tombo; Jean C Bopassa
Journal:  Biochem Biophys Res Commun       Date:  2019-10-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.